Clinigen establishes ‘on-demand’ clinical trial supply chain

By Maggie Lynch

- Last updated on GMT

(Image: Getty/betnoire)
(Image: Getty/betnoire)
Clinigen’s newly announced business, Clinical Trial Service, will establish an on-demand supply chain for clinical trials and extends agreement with its partner Accord.

Clinigen and Accord, a generic pharmaceuticals company, have been partners since 2012 delivering oncology injectable products, including carboplatin, cisplatin and paclitaxel, to clinical trials.

The partnership has grown over the past several years, which a spokesperson for Clinigen said has led to the expansion of the relationship “to bring more products to customers.”

The extended agreement now covers Accord’s European solid dose products, including those in the central nervous system, autoimmune, diabetes, and anti-viral therapy areas.

“The extension of the exclusive agreement will allow Clinigen to have an even larger product offering accessible to our customers ‘on-demand.’ This gives our customers the most flexibility to meet their supply chain needs with the highest quality, and most secure supply chain,” ​the spokesperson explained.

Products needed for clinical trials will be held in large batch sizes on consignment to be dispatched immediately. Any Clinigen client running clinical trials will have the on-demand supply service available to them. With this, clients will be offered access to products from Accord’s generic oncology injectable product portfolio.

According to Clinigen, this is the first type of service dedicated to providing on demand access to products for clinical trials in the pharmaceutical industry.

Speaking of the partnership advantages a spokesperson for Clinigen told us, “Clinigen was able to partner with a strong manufacturer and provide customers with a dedicated source of many critical products with assurance of quality. Accord was able to tap into Clinigen's global scale and access a broad base of customers with a simplified, supply chain.”

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Products

View more

Webinars